| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | RA Capital Management, LLC | 39.65M (567.91%) | 0.00 Increased by 0.00% | Jun 30, 25 |
| 2 | Paradigm Biocapital Advisors LP | 6.46M (92.50%) | 0.00 Increased by 0.00% | Jun 30, 24 |
| 3 | 5AM Venture Management, LLC | 6.36M (91.13%) | 0.00 Increased by 0.00% | Jun 30, 25 |
| 4 | LAURION CAPITAL MANAGEMENT LP | 2.53M (36.18%) | -657.44K Decreased by -26.03% | Jun 30, 24 |
| 5 | Hudson Bay Capital Management LP | 2.47M (35.33%) | 2.47M Increased by +100.00% | Sep 30, 24 |
| 6 | FMR Inc | 2.09M (29.98%) | -4.33M Decreased by -206.90% | Jun 30, 25 |
| 7 | Vanguard Group Inc | 1.92M (27.44%) | -24.62K Decreased by -1.29% | Jun 30, 25 |
| 8 | UBS Group AG | 1.53M (21.94%) | 1.52M Increased by +99.45% | Jun 30, 25 |
| 9 | COWEN AND COMPANY, LLC | 1.22M (17.48%) | 1.22M Increased by +100.00% | Sep 30, 24 |
| 10 | Woodline Partners LP | 1.11M (15.92%) | 0.00 Increased by 0.00% | Mar 31, 24 |
| 11 | Johnson & Johnson | 1.07M (15.39%) | 0.00 Increased by 0.00% | Jun 30, 25 |
| 12 | Artal Group S A | 1.00M (14.32%) | -1.35M Decreased by -134.74% | Mar 31, 24 |
| 13 | State Street Corporation | 657.71K (9.42%) | 49.70K Increased by +7.56% | Mar 31, 24 |
| 14 | Baker Bros Advisors LP | 633.85K (9.08%) | 0.00 Increased by 0.00% | Sep 30, 23 |
| 15 | Jane Street Group LLC | 525.61K (7.53%) | 330.86K Increased by +62.95% | Jun 30, 25 |
| 16 | Sarissa Capital Management LP | 508.02K (7.28%) | 0.00 Increased by 0.00% | Jun 30, 25 |
| 17 | HRT FINANCIAL LLC | 474.57K (6.80%) | 474.57K Increased by +100.00% | Jun 30, 25 |
| 18 | Renaissance Technologies Corp | 468.11K (6.71%) | -233.32K Decreased by -49.84% | Jun 30, 25 |
| 19 | Geode Capital Management, LLC | 435.56K (6.24%) | -2.45K Decreased by -0.56% | Jun 30, 25 |
| 20 | Scientech Research LLC | 403.86K (5.79%) | 403.86K Increased by +100.00% | Jun 30, 25 |
| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | Fidelity Growth Compy Commingled Pl O | 2.12M (30.34%) | 0.00 Increased by 0.00% | Aug 31, 24 |
| 2 | Fidelity Growth Compy Commingled Pl S | 1.96M (28.12%) | -207.80K Decreased by -10.58% | Apr 30, 25 |
| 3 | Fidelity® Growth Company | 1.43M (20.51%) | 0.00 Increased by 0.00% | Oct 31, 23 |
| 4 | Vanguard US Total Market Shares ETF | 1.39M (19.85%) | 0.00 Increased by 0.00% | Sep 30, 24 |
| 5 | Vanguard Total Stock Mkt Idx Inv | 1.36M (19.42%) | -29.89K Decreased by -2.21% | Jul 31, 25 |
| 6 | Fidelity Growth Company Fund | 1.27M (18.25%) | -140.15K Decreased by -11.00% | Apr 30, 25 |
| 7 | Fidelity® Select Biotechnology | 1.11M (15.97%) | 0.00 Increased by 0.00% | Oct 31, 23 |
| 8 | iShares Russell 2000 ETF | 776.40K (11.12%) | -6.20K Decreased by -0.80% | Apr 30, 24 |
| 9 | Fidelity VIP Growth Initial | 618.39K (8.86%) | 0.00 Increased by 0.00% | Jul 31, 25 |
| 10 | VIP Growth Initial | 618.39K (8.86%) | 0.00 Increased by 0.00% | Oct 31, 23 |
| 11 | Fidelity Select Biotechnology | 614.60K (8.80%) | 0.00 Increased by 0.00% | Sep 30, 24 |
| 12 | Fidelity Capital Appreciation | 610.40K (8.74%) | 0.00 Increased by 0.00% | Jun 30, 25 |
| 13 | Fidelity® Capital Appreciation | 610.40K (8.74%) | 0.00 Increased by 0.00% | Oct 31, 23 |
| 14 | Fidelity® Growth Company K6 | 603.64K (8.65%) | 0.00 Increased by 0.00% | Oct 31, 23 |
| 15 | Fidelity Advisor® Equity Growth I | 474.94K (6.80%) | 0.00 Increased by 0.00% | Oct 31, 23 |
| 16 | Fidelity Advisor Equity Growth I | 474.17K (6.79%) | 0.00 Increased by 0.00% | Jul 31, 25 |
| 17 | Fidelity Growth Company K6 | 438.61K (6.28%) | -43.30K Decreased by -9.87% | Apr 30, 25 |
| 18 | Vanguard Institutional Extnd Mkt Idx Tr | 401.04K (5.74%) | -118.59K Decreased by -29.57% | Jul 31, 25 |
| 19 | Fidelity Small Cap Index | 384.43K (5.51%) | 13.14K Increased by +3.42% | Jun 30, 24 |
| 20 | iShares Russell 2000 Value ETF | 383.06K (5.49%) | 0.00 Increased by 0.00% | Apr 30, 24 |